The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Peptide Reclassification 2026: What It Means for Providers The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University BPC 157 & The Gut Brain Axis: A Practitioner's Definitive Review of the Evidence